Proximal tubule handling of two human Bence Jones proteins (neutral and acidic BJP) was evaluated using protein A-gold labelling. After 30 min of acute light-chain infusion into 6 rats (alone or in combination with dinitrophenyl-aminopropyl-methylamine [DAMP]), kidney biopsies were processed for immunoelectron microscopy. Antibodies directed at monoclonal lambda light chains, mannose-6-phosphate cation-independent receptor (MPR) and DAMP were used.Labelling density (number of pA-gold particles/µm2), expressed as median (25–75 percentiles), differed (p < 0.05) between the two BJP, being 94.5 (32.9–212.5) vs. 19.4 (3.7–45.6) pA-gold/µm2 in endocytic vacuoles, and 297.3 (207.1–382.1) vs. 83.2 (16.6–197.0) pA-gold/µm2 in non-vacuolar electrondense endosome-lysosome structures. Labelling density for MPR was 47.7 (22.2–84.6) vs. 4.0 (2.7–6.3) pA-gold/µm2. The area of MPR-labelled structures was also different, i.e.: 0.2 (0.1–0.4) vs. 0.9 (0.5–1.8) µm2. The endosome-lysosome pH distribution range differed significantly: 6.8 (6.4–7.0) vs. 6.3 (5.8–7.0). There was a significant accumulation of neutral BJP in endocytic structures, an acidification deficit of pre-lysosomes/lysosomes and MPR retention, suggestive of defective receptor recycling with this BJP. Interference with the physiological process of lysosomal acidification may be an important mechanism of higher nephrotoxicity in some BJP.

Keywords:
Bence Jones proteins, Endo-lysosomal system, Multiple myeloma
1.
Cohen DJ, Sherman WH, Osserman EF, Appel GB: Acute renal failure in patients with multiple myeloma. Am J Med 1984;76:247–256.
2.
Cooper EH, Forbes MA, Crockson RA, MacLennan IC: Proximal renal tubular function in myelomatosis: observations in the Fourth Medical Research Council trial. J Clin Pathol 1984;37:852–858.
3.
Pasquali S, Zucchelli P, Casanova S, Cagnoli L, Confalonieri R, Pozzi C, Banfi G, Lupo A, Bertani T: Renal histological lesions and clinical syndromes in multiple myeloma. Clin Nephrol 1987;27:222–228.
4.
Solomon A, Weiss DT, Kattine AA: Nephrotoxic potential of Bence Jones proteins. N Engl J Med 1991;324:1845–1851.
5.
Clyne DH, Brendstrup L, First MR, Pesce AJ, Finkel PN, Pollak VE, Pirani CL: Renal effects of intraperitoneal kappa chain injection. Induction of crystals in renal tubular cells. Lab Invest 1974;31:131–142.
6.
Koss MN, Pirani CL, Osserman EF: Experimental Bence Jones cast nephropathy. Lab Invest 1976;34:579–591.
7.
Weiss JH, Williams RH, Galla JG, Gottschall JL, Rees ED, Bhathena D, Luke RG: Pathophysiology of acute Bence-Jones protein nephrotoxicity in the rat. Kidney Int 1981;20:198–210.
8.
Melcion C, Mougenot B, Baudouin B, Ronco P, Moulonguet-Doleris L, Vanhille P, Beaufils M, Morel-Maroger L, Verroust P, Richet G: Renal failure in myeloma: relationship with isoelectric point of immunoglobulin light chains. Clin Nephrol 1984;22:138–143.
9.
Christensen EI, Carone FA, Rennke HG: Effect of molecular charge on endocytic uptake of ferritin in renal proximal tubule cells. Lab Invest 1981;44:351–358.
10.
Christensen EI, Rennke HG, Carone FA: Renal tubular uptake of protein: effect of molecular charge. Am J Physiol 1983;244:F436–F441.
11.
Ford DM, Dahl RH, Lamp CA, Molitoris BA: Apically and basolaterally internalized aminoglycosides colocalize in LLC-PK1 lysosomes and alter cell function. Am J Physiol 1994;266:C52–C57.
12.
Peterson DR, Kubillus S, Binstock W, Zikos D: Effects of charge on membrane processing in the proximal nephron. Am J Physiol 1989;256:C304–C309.
13.
Sundin DP, Cohen M, Dahl R, Falk S, Molitoris BA: Characterization of the beta-2-microglobulin endocytic pathway in rat proximal tubule cells. Am J Physiol 1994;267:F380–F389.
14.
Maack T: Renal handling of low molecular weight proteins. Am J Med 1975;58:57–64.
15.
Wall DA, Maack T: Endocytic uptake, transport, and catabolism of proteins by epithelial cells. Am J Physiol 1985;248:C12–C20.
16.
Maack T, Park CH: Endocytosis and lysosomal hydrolysis of proteins in proximal tubules. Methods Enzymol 1990;191:341–354.
17.
Nuoffer C, Balch WE: GTPases: multifunctional molecular switches regulating vesicular traffic. Annu Rev Biochem 1994;63:949–990.
18.
Griffiths G, Hoflack B, Simons K, Mellman I, Kornfeld S: The mannose-6-phosphate receptor and the biogenesis of lysosomes. Cell 1988;52:329–341.
19.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
20.
Norden AG, Fulcher LM, Flynn FV: Detection of Bence Jones protein by isoelectric focussing of unconcentrated urine followed by nitrocellulose blotting and immunoperoxidase staining. Clin Chim Acta 1985;153:149–156.
21.
Grabar P, Williams CA: Méthode permettant l’étude conjuguée des propriétés électrophorétiques et immunochimiques d’un mélange de protéines. Application au sérum sanguin. Biochim Biophys Acta 1953;10:193–194.
22.
Towbin H, Staefrelin T, Bordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc Natl Acad Sci USA 1979;76:4350–4355.
23.
Barta JR, Corbin J: Use of immunogold-silver staining to visualize antibody-antigen complexes on LR White embedded tissues prior to electron microscopy. J Electron Microsc Tech 1990;16:83–84.
24.
Roth J, Heitz PU: Immunolabeling with the protein A-gold technique: an overview. Ultrastruct Pathol 1989;13:467–484.
25.
Nakajima M, Mathews DC, Hewitson T, Kincaid-Smith P: Modified immunogold labelling applied to the study of protein droplets in glomerular disease. Virchows Archiv. A, Pathol Anat Histopathol 1989;415:489–499.
26.
Orci L, Ravazzola M, Amherdt M, Madsen O, Perrelet A, Vassalli JD, Anderson RG: Conversion of proinsulin to insulin occurs coordinately with acidification of maturing secretory vesicles. J Cell Biol 1986;103:2273–2281.
27.
Wochner RD, Strober W, Waldmann TA: The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments. J Exp Med 1967;126:207–221.
28.
Batuman V, Dreisbach AW, Cyran J: Light-chain binding sites on renal brush border membranes. Am J Physiol 1990;258:F1259–F1265.
29.
Nielsen JT: Handling of proteins in isolated and in vivo perfused proximal tubules from rabbit kidney. Dan Med Bull 1990;37:197–210.
30.
Roos A, Boron WF: Intracellular pH. Physiol Rev 1981;61:296–434.
31.
Van Deurs B, Christensen EI: Endocytosis in kidney proximal tubule cells and cultured fibroblasts: a review of the structural aspects of membrane recycling between the plasma membrane and endocytic vacuoles. Eur J Cell Biol 1984;33:163–173.
32.
Gruenberg J, Howell KE: Membrane traffic in endocytosis; insights from cell-free assays. Annu Rev Cell Biol 1989;5:453–481.
33.
Park RD, Sullivan PC, Storrie B: Hypertonic sucrose inhibition of endocytic transport suggests multiple early endocytic compartments. J Cell Physiol 1988;135:443–450.
34.
Kornfeld S, Mellman I: The biogenesis of lysosomes. Annu Rev Cell Biol 1989;5:483–525.
35.
Bomsel M, Parton R, Kuznetsov SA, Schroer TA, Gruenberg J: Microtubule- and motor-dependent fusion in vitro between apical and basolateral endocytic vesicles from MDCK cells. Cell 1990;64:719–731.
36.
Mullock BM, Branch WJ, van-Schaik M, Gilbert LK, Luzio JP: Reconstitution of an endosome-lysosome interaction in a cell-free system. J Cell Biol 1989;108:2093–2099.
37.
Duncan JR, Kornfeld S: Intracellular movement of two mannose-6-phosphate receptors: Return to the Golgi apparatus. J Cell Biol 1988;106:617–628.
38.
Ledingham JG: Tubular toxicity of filtered proteins. Am J Nephrol 1990;10(suppl 1):52–57.
39.
Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D: Renal filtration, transport and metabolism of low-molecular weight proteins: a review. Kidney Int 1979;16:251–270.
40.
Gonzalez-Noriega A, Grubb JH, Talkad V, Sly WS: Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling. J Cell Biol 1980;85:839–852.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.